Evidence map›Paper›PMID 34880909›Full record

ArticleFrontiers in genetics2021

Construction of a Support Vector Machine-Based Classifier for Pulmonary Arterial Hypertension Patients.

Zhenglu Shang, Jiashun Sun, Jingjiao Hui, Yanhua Yu, Xiaoyun Bian, Bowen Yang, Kewu Deng, Li Lin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhenglu ShangDepartment of Cardiology, Wuxi Huishan District People's Hospital, Wuxi, China.
Jiashun SunDepartment of Hospital, Wuxi Huishan District People's Hospital, Wuxi, China.
Jingjiao HuiDepartment of Cardiology, Wuxi Huishan District People's Hospital, Wuxi, China.
Yanhua YuDepartment of Cardiology, Wuxi Huishan District People's Hospital, Wuxi, China.
Xiaoyun BianDepartment of Cardiology, Wuxi Huishan District People's Hospital, Wuxi, China.
Bowen YangDepartment of Cardiology, Wuxi Huishan District People's Hospital, Wuxi, China.
Kewu DengDepartment of Cardiology, Beijing Tongren Hospital, Beijing, China.
Li LinDepartment of Cardiology, Shanghai Dongfang Hospital, Shanghai, China.
Wuqing District People's Hospital · CNBeijing Tongren Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is a disease leading to right heart failure and death due to increased pulmonary arterial tension and vascular resistance. So far, PAH has not been fully understood, and current treatments are much limited. Gene expression profiles of healthy people and PAH patients in GSE33463 dataset were analyzed in this study. Then 110 differentially expressed genes (DEGs) were obtained. Afterward, the PPI network based on DEGs was constructed, followed by the analysis of functional modules, whose results showed that the genes in the major function modules significantly enriched in immune-related functions. Moreover, four optimal feature genes were screened from the DEGs by support vector machine-recursive feature elimination (SVM-RFE) algorithm (EPB42, IFIT2, FOSB, and SNF1LK). The receiver operating characteristic curve showed that the SVM classifier based on optimal feature genes could effectively distinguish healthy people from PAH patients. Last, the expression of optimal feature genes was analyzed in the GSE33463 dataset and clinical samples. It was found that EPB42 and IFIT2 were highly expressed in PAH patients, while FOSB and SNF1LK were lowly expressed. In conclusion, the four optimal feature genes screened here are potential biomarkers for PAH and are expected to be used in early diagnosis for PAH.

Indexed as

biomarkerclassifierNapulmonary arterial hypertensionSVM-RFE

Identifiers

PMID34880909
PMCPMC8647811
OpenAlexW3216465575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.